Biden’s FDA Needs Course Corrections to Increase Covid-19 Testing

February 12, 2021By: Jeffrey N. Gibbs & Gail H. Javitt Download PDF

The FDA under President Joe Biden has the opportunity to improve the availability of Covid-19
testing. Hyman, Phelps & McNamara P.C. attorneys say the FDA can start by eliminating needless
hurdles in the regulatory approval process, providing greater clarity, and applying criteria

Related Professionals